Literature DB >> 32894175

Correction to: Classical galactosemia: neuropsychological and psychosocial functioning beyond intellectual abilities.

Mendy M Welsink-Karssies1, Kim J Oostrom2, Merel E Hermans3, Carla E M Hollak4, Mirian C H Janssen5, Janneke G Langendonk6, Esmee Oussoren7, M Estela Rubio Gozalbo8, Maaike de Vries9, Gert J Geurtsen3, Annet M Bosch10.   

Abstract

An amendment to this paper has been published and can be accessed via the original article.

Entities:  

Year:  2020        PMID: 32894175      PMCID: PMC7487470          DOI: 10.1186/s13023-020-01447-z

Source DB:  PubMed          Journal:  Orphanet J Rare Dis        ISSN: 1750-1172            Impact factor:   4.123


Correction to: Orphanet Journal of Rare Diseases (2020) 15:42 https://doi.org/10.1186/s13023-019-1277-0 Following the original article’s publication [1] the authors informed us of the following errors: 1. Author M. Estela Rubio Gozalbo’s first and last names were captured incorrectly. The author’s first names are M. Estela, while last names are Rubio Gozalbo. The correct author’s name has been updated in the original article [1] and shown in the author list of this Correction. 2. In Table 2 ‘Digit span’ and ‘GIT-2’ are tests and should be preceded by a - just like the other tests in the table.
Table 2

Cognitive Functioning Results

DomainNResults patientsP-valueaNFSIQ 50–69 (Group 1)NFSIQ 70–85(Group 2)NFSIQ > 85(Group 3)P-valueb
Learning & Memory
 - AVLT Immediate Recall1946.0 (9–61)0.029440.0 (9–46)1145.00 (35–61)449.50 (47–51)0.121
 - AVLT Delayed Recall1946.0 (15–65)0.545449.5 (15–58)1146.00 (34–65)450.00 (43–55)0.956
 - AVLT Delayed / Immediate1952.0 (38–65)0.445455.5 (43–62)1152.00 (38–65)452.00 (39–62)0.803
 - Digit span3543.0 (20–63)< 0.0005c830.00 (20–57)1543.00 (27–60)1248.50 (33–63)0.017
Visuospatial functioning
 - GIT-2a spatial test1936.0 (23–50)< 0.0005c426.5 (23–40)1135.0 (28–40)441.5 (40–50)0.019
 - Block design4238.5 (20–53)< 0.0005c930.0 (20–40)1737.0 (27–50)1637.0 (33–53)< 0.0005c
Executive functioning
Inhibition
 - Stroop III (Inhibition)2545.0 (20–56)0.003c627.0 (20–49)1348.00 (22–56)646.0 (35–53)0.078
 - Stroop III/II (Interference)2549.0 (30–66)0.537643.0 (30–60)1350.00 (31–66)647.5 (40–63)0.642
Cognitive flexibility
 - WCST Total number of errors2450.5 (27–67)0.988646.0 (27–50)1251.50 (37–67)652.0 (39–64)0.134
 - WCST Perseverative responses2451.0 (30–81)0.626646.0 (33–52)1253.00 (30–81)652.0 (35–73)0.278
 - WCST Percent conceptual level responses2449.5 (27–64)0.951648.0 (27–51)1252.00 (39–64)651.0 (37–62)0.270
 - TMT B/A2544.0 (27–57)0.002c645.0 (27–50)1343.00 (27–57)648.5 (40–57)0.510
 - Letter fluency1937.0 (27–67)0.001c431.0 (28–38)1139.00 (31–67)434.0 (27–56)0.143
Mental Speed
 - Stroop I (Color naming)2540.0 (25–61)0.001c635.0 (25–43)1343.00 (35–61)646.5 (33–55)0.077
 - Stroop II (Word reading)2537.0 (20–56)< 0.0005c630.0 (20–40)1343.00 (20–56)639.0 (33–56)0.063
 - TMT A (Digit sequencing)2552.0 (20–67)0.352650.5 (20–59)1356.00 (43–67)647.5 (33–67)0.173
 - TMT B (Digit-Letter-Switching)2545.0 (20–58)0.003c633.5 (20–47)1346.00 (20–58)645.0 (33–56)0.111
 - Symbol search4143.0 (20–67)< 0.0005c923.0 (20–50)1740.00 (27–67)1547.0 (40–60)0.001c
 - Substitution4240.0 (23–57)< 0.0005c930.0 (23–47)1740.00 (30–57)1643.0 (33–53)0.006

Data reported in T-scores, median (ranges). a Patient data vs. normative data (T-score 50), b Comparison between FSIQ groups, Significant after Bonferroni-Holm correction. FSIQ full scale IQ, AVLT auditory verbal learning test, GIT-II groninger intelligentie test 2, Stroop stroop color word test, WCST wisconsin card sorting test, TMT trail making test

Furthermore, ‘Responses’ is not a domain and should therefore be deleted. Finally, ‘Cconceptual’ should be corrected to ‘conceptual’. The table is shown here corrected. Cognitive Functioning Results Data reported in T-scores, median (ranges). a Patient data vs. normative data (T-score 50), b Comparison between FSIQ groups, Significant after Bonferroni-Holm correction. FSIQ full scale IQ, AVLT auditory verbal learning test, GIT-II groninger intelligentie test 2, Stroop stroop color word test, WCST wisconsin card sorting test, TMT trail making test 3. The grey box for ‘test result better than expected’ is missing from the legends of Tables 4 and 5.
Table 4

Individual Results, Adult Patients

ap.Ser135Leu homozygous patient. VIQ Verbal IQ, PIQ Performal IQ, FSIQ Full Scale IQ, Stroop Stroop Color Word Test, WCST Wisconsin Card Sorting Test, PR Perseverative Responses, CLR Conceptual Level Responses, TMT Trail Making Test, AVLT Auditory Verbal Learning Test, GIT-II Groninger Intelligentie Test 2, HADS Hospital Anxiety and Depression Scale, BRIEF Behavior Rating Inventory of Executive Function, SRS Social Responsiveness Scale

X no test result, ■ test result worse than expected,  test result better than expected, □ test result as expected

*X no result, - - T-score on total scale in clinical range, - T-score on total scale in subclinical range, □ T-score on total scale within normal range

Table 5

Individual Results, Pediatric Patients

ap.Ser135Leu homozygous patient, b Variant patient, VIQ Verbal IQ, PIQ Performal IQ, FSIQ Full Scale IQ, NI NEPSY Inhibition, Stroop Stroop Color Word Test, RS Response Set, AA Auditory Attention, WCST Wisconsin Card Sorting Test, PR Perseverative responses, CLR Conceptual Level Responses, TMT Trail Making Test, AVLT Auditory Verbal Learning Test, TCT Total Completion Time, GIT-II Groninger Intelligentie Test 2, CBCL 6–18y Child Behavior Checklist 6–18 years, YSR Youth Self Report, BRIEF Behavior Rating Inventory of Executive Function, SRS Social Responsiveness Scale

X no test result, ■ test result worse than expected, test result better than expected, □ test result as expected

*X no result, - - T-score on total scale in clinical range, - T-score on total scale in subclinical range, □ T-score on total scale within normal range

The two tables with their respective legends are shown here corrected. Individual Results, Adult Patients ap.Ser135Leu homozygous patient. VIQ Verbal IQ, PIQ Performal IQ, FSIQ Full Scale IQ, Stroop Stroop Color Word Test, WCST Wisconsin Card Sorting Test, PR Perseverative Responses, CLR Conceptual Level Responses, TMT Trail Making Test, AVLT Auditory Verbal Learning Test, GIT-II Groninger Intelligentie Test 2, HADS Hospital Anxiety and Depression Scale, BRIEF Behavior Rating Inventory of Executive Function, SRS Social Responsiveness Scale X no test result, ■ test result worse than expected,  test result better than expected, □ test result as expected *X no result, - - T-score on total scale in clinical range, - T-score on total scale in subclinical range, □ T-score on total scale within normal range Individual Results, Pediatric Patients ap.Ser135Leu homozygous patient, b Variant patient, VIQ Verbal IQ, PIQ Performal IQ, FSIQ Full Scale IQ, NI NEPSY Inhibition, Stroop Stroop Color Word Test, RS Response Set, AA Auditory Attention, WCST Wisconsin Card Sorting Test, PR Perseverative responses, CLR Conceptual Level Responses, TMT Trail Making Test, AVLT Auditory Verbal Learning Test, TCT Total Completion Time, GIT-II Groninger Intelligentie Test 2, CBCL 6–18y Child Behavior Checklist 6–18 years, YSR Youth Self Report, BRIEF Behavior Rating Inventory of Executive Function, SRS Social Responsiveness Scale X no test result, ■ test result worse than expected, test result better than expected, □ test result as expected *X no result, - - T-score on total scale in clinical range, - T-score on total scale in subclinical range, □ T-score on total scale within normal range 4. In Table S8 of the Additional file 1, some rows have shifted. ‘Anxiety & Depression’ and ‘Social Functioning’ should be shown on separate lines. HADS should be in line with ‘Anxiety & Depression’ and SRS with ‘Social Functioning’. In addition, subsequent references should be renumbered as 35–49. The corrected Additional file 1 accompanies this Correction. Additional file 1: Table S8. The Neuropsychological Assessment.
  1 in total

1.  Classical galactosemia: neuropsychological and psychosocial functioning beyond intellectual abilities.

Authors:  Mendy M Welsink-Karssies; Kim J Oostrom; Merel E Hermans; Carla E M Hollak; Mirian C H Janssen; Janneke G Langendonk; Esmee Oussoren; M Estela Rubio Gozalbo; Maaike de Vries; Gert J Geurtsen; Annet M Bosch
Journal:  Orphanet J Rare Dis       Date:  2020-02-07       Impact factor: 4.123

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.